ES549853A0 - Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos. - Google Patents

Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.

Info

Publication number
ES549853A0
ES549853A0 ES549853A ES549853A ES549853A0 ES 549853 A0 ES549853 A0 ES 549853A0 ES 549853 A ES549853 A ES 549853A ES 549853 A ES549853 A ES 549853A ES 549853 A0 ES549853 A0 ES 549853A0
Authority
ES
Spain
Prior art keywords
anilids
procedure
preparation
arylacetic acids
substituted arylacetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549853A
Other languages
English (en)
Other versions
ES8704881A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of ES8704881A1 publication Critical patent/ES8704881A1/es
Publication of ES549853A0 publication Critical patent/ES549853A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES549853A 1984-12-11 1985-12-11 Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos. Expired ES8704881A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59261197A JPS61140556A (ja) 1984-12-11 1984-12-11 新規なアリ−ル酢酸アニリド誘導体

Publications (2)

Publication Number Publication Date
ES8704881A1 ES8704881A1 (es) 1987-04-16
ES549853A0 true ES549853A0 (es) 1987-04-16

Family

ID=17358490

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549853A Expired ES8704881A1 (es) 1984-12-11 1985-12-11 Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.

Country Status (4)

Country Link
EP (1) EP0184822A3 (es)
JP (1) JPS61140556A (es)
AU (1) AU5106585A (es)
ES (1) ES8704881A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617653D0 (en) * 1986-07-18 1986-08-28 Ici Plc Amide derivatives
FR2730995B1 (fr) * 1995-02-23 1997-04-04 Cird Galderma Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US6444849B1 (en) * 1997-06-25 2002-09-03 Mitsubishi Chemical Corporation Amide derivatives
US6407120B1 (en) 1999-02-18 2002-06-18 Pfizer Inc. Neuropeptide Y antagonists
EP1033366A3 (en) * 1999-02-18 2000-12-27 Pfizer Products Inc. Amide derivatives useful as Neuropeptide Y (NPY) antagonists
DE10234057A1 (de) * 2002-07-26 2004-02-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB828695A (en) * 1955-03-10 1960-02-24 Farmaceutici Italia N-p-hydroxylphenyl amides with choleretic action

Also Published As

Publication number Publication date
EP0184822A3 (en) 1987-12-09
AU5106585A (en) 1986-06-19
ES8704881A1 (es) 1987-04-16
EP0184822A2 (en) 1986-06-18
JPS61140556A (ja) 1986-06-27

Similar Documents

Publication Publication Date Title
ES544524A0 (es) Un procedimiento para la preparacion de acidos indol-2-alcanoicos.
ES544439A0 (es) Procedimiento para la preparacion de acidos a,w -dicarboxi- licos
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES544852A0 (es) Un procedimiento para la preparacion de derivados sustituidos ester benzoato de 3-hidroximorfinanos.
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES544527A0 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas.
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES540380A0 (es) Un procedimiento para la preparacion de alquenilcarboxilatos de polioxialquenilo.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES548595A0 (es) Un procedimiento para la preparacion de composiciones de acidos hidrocarbilsulfonicos.
ES539543A0 (es) Un procedimiento para la preparacion de nuevos compuestos de oxadiazinona.
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.